YoVDO

CONQUEST: A Platform Clinical Trial for Scleroderma-Associated Lung Disease

Offered By: SRFCURE via YouTube

Tags

Clinical Trials Courses Rheumatology Courses Pulmonology Courses Medical Research Courses Biopharmaceuticals Courses Scleroderma Courses Interstitial Lung Disease Courses Systemic Sclerosis Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Learn about CONQUEST, an innovative phase 2b international platform clinical trial accelerating scleroderma research. Explore how this multicenter study, developed by the SRF and partner biopharmaceutical companies, investigates multiple therapies for treating interstitial lung disease (ILD) associated with systemic sclerosis (SSc-ILD). Gain insights from experts Dr. Toby Maher, Professor of Clinical Medicine at Keck School of Medicine of USC, and Dr. Dinesh Khanna, Professor of Medicine at the University of Michigan, as they present the groundbreaking approach to advancing treatments for this complex condition.

Syllabus

CONQUEST, a Platform Clinical Trial


Taught by

SRFCURE

Related Courses

Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines
Massachusetts Institute of Technology via edX Taking on Autoimmune Diseases with Worms
The Aspen Institute via YouTube Development of an On-Chip Binding Assay to Select Clones Expressing Bispecific Antibodies
Labroots via YouTube The Experience of Development and Verification of Analytical Platforms for Cellular and Gene Therapy
Labroots via YouTube Safety First - A Comprehensive Look at Cell and Gene Therapy Testing
Labroots via YouTube